Cite
HARVARD Citation
Illini, O. et al. (2021). Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program. Therapeutic advances in medical oncology. p. . [Online].